Tag: Mirtazapine

May 20, 2026 / Mohammed looti

REMERON

REMERON: Clinical Profile and Pharmacological Landscape of Mirtazapine Mirtazapine, clinically recognized and widely distributed under the brand name Remeron, stands as a prominent therapeutic agent within the category of atypical antidepressants. Specifically classified as a noradrenergic and specific serotonergic antidepressant (NaSSA), this compound represents a significant departure from conventional monoaminergic therapies. Its primary clinical indication […]

October 19, 2025 / Mohammed looti

MIRTAZAPINE

Mirtazapine The Core Definition and Mechanism Mirtazapine is an atypical antidepressant drug primarily prescribed for the treatment of Major Depressive Disorder (MDD). Unlike the more commonly prescribed Selective Serotonin Reuptake Inhibitors (SSRIs) or Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Mirtazapine is classified as a Noradrenergic and Specific Serotonergic Antidepressant (NaSSA). Its mechanism of action is significantly varied […]